Impel NeuroPharma Inc (NASDAQ:IMPL)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - IMPL

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - IMPL

  • Market Cap$182.220m
  • SymbolNASDAQ:IMPL
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS45258K1097

Company Profile

Impel NeuroPharma Inc is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system. Its pipeline of proprietary product candidates includes INP107 for the treatment of OFF episodes in Parkinson's Disease.

Latest IMPL news

Currently there for this company. Visit our news hub for other news .